Madeline Choi
Algemeen Directeur bij DNAGO.Ai
Vermogen: 1 M $ op 31-05-2024
Profiel
Madeline Choi is currently the Chief Executive Officer at DNAGO.Ai.
Prior to this, she worked as a Secretary at Hi-Great Group Holding Co. from 2020 to 2022.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-12-2022 | 1 000 000 ( 1.06% ) | 1 M $ | 31-05-2024 |
Actieve functies van Madeline Choi
| Bedrijven | Functie | Begin |
|---|---|---|
DNAGO.Ai
 DNAGO.Ai Medical/Nursing ServicesHealth Services Part of Oncologix Tech, Inc., DNAGO.Ai is a company that specializes in cell banking technology, specifically in dermal papilla cells. The company is based in Irvine, CA. The company also conducts research in other areas and have a research institute. The CEO of the company is Madeline Choi. DNAGO.Ai was acquired by Oncologix Tech, Inc. on June 30, 2022. | Algemeen Directeur | - |
Eerdere bekende functies van Madeline Choi
| Bedrijven | Functie | Einde |
|---|---|---|
| HI-GREAT GROUP HOLDING COMPANY | Bedrijfssecretaris | 22-09-2022 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HI-GREAT GROUP HOLDING COMPANY | Distribution Services |
| Bedrijven in privébezit | 1 |
|---|---|
DNAGO.Ai
DNAGO.Ai Medical/Nursing ServicesHealth Services Part of Oncologix Tech, Inc., DNAGO.Ai is a company that specializes in cell banking technology, specifically in dermal papilla cells. The company is based in Irvine, CA. The company also conducts research in other areas and have a research institute. The CEO of the company is Madeline Choi. DNAGO.Ai was acquired by Oncologix Tech, Inc. on June 30, 2022. | Health Services |
